Nath Bio-Technologies Limited, a active public limited company, was established on 27 August 1991 in Aurangabad, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U01110MH1991PLC063077. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Its leadership includes Sweta Akash Kagliwal (Director), Jeevanlata Nandkishor Kagliwal (Director), Satish Laxminarayan Kagliwal (Director). Past directors included Akash Nandkishor Kagliwal, Shrirang Shrikishan Agrawal, Nandkishor Laxminarayan Kagliwal. It holds no open charges and ₹7.17 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Nath Housenath Rd, Aurangabad, Maharashtra, 431005.
U01110MH1991PLC063077
063077
27 August 1991
₹1.00 Cr
₹1.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nath Bio-Technologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sweta Akash Kagliwal | Director | 25 Mar 2019 | Current |
| Jeevanlata Nandkishor Kagliwal | Director | 25 Mar 2019 | Current |
| Satish Laxminarayan Kagliwal | Director | 27 Aug 1991 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2019 | Past |
| Pramod Abcsdd | Director | 15 Mar 2012 | Past |
| Pramod Abcsdd | Director | 25 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nath Bio-Technologies Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.28% increase in profit. The company's net worth dipped by a decrease of 0.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Nath Bio-Technologies had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹7,166,700.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 1994 | State Bank Of Hydrabad | ₹6.89 M | Satisfied |
| 14 May 1992 | The Saraswat Cop Operative Baqnk Central Admin. | ₹0.28 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nath Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nath Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nath Bio-Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nath Bio-Technologies Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Nath Bio-Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Sweta Akash Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was completed.
Progress on Jeevanlata Nandkishor Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was documented.
Progress on A charge registered on 14 May 1992 via Charge ID 90162612 with The Saraswat Cop Operative Baqnk Central Admin. was fully satisfied on 01 Jul 2008. was documented.
A charge registered on 19 Mar 1994 via Charge ID 90162878 with State Bank Of Hydrabad was fully satisfied on 13 May 2008. was recorded as a recent event.
The CIN of Nath Bio-Technologies Limited is U01110MH1991PLC063077.
Nath Bio-Technologies Limited is headquartered at Nath Housenath Rd, Aurangabad, Maharashtra, 431005.
Nath Bio-Technologies Limited was incorporated on 27 August 1991.
The current directors of Nath Bio-Technologies Limited are
The primary industry of Nath Bio-Technologies Limited is Professional, Scientific And Technical.
Nath Bio-Technologies Limited is unlisted.
The authorized capital of Nath Bio-Technologies Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Nath Bio-Technologies Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX